Sort
40,608 grants matching “prostate cancer”
Genomic and Genomic Variation in Prostate Cancer
$981,414Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Nanotechnology for Multiplexed and Intraoperative Cancer Detection
$980,999Shuming Nie · Emory University · RC2 · FY2009 · CA
Comprehensive validation and commercial readiness of SpliceIO, a software platform for neoantigen discovery using RNA-seq data
$980,257Martin Akerman · Envisagenics, Inc. · R44 · FY2023 · CA
Missouri Valley Cancer Consortium CCOP
$980,000Missouri Valley Cancer Consortium, Inc. · U10 · FY2002 · CA
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$979,999David V Conti · University Of Southern California · U01 · FY2023 · CA
Leveraging Diversity in Cancer Epidemiology Cohorts and Novel Methods to Improve Polygenic Risk Scores
$979,999David V Conti · University Of Southern California · U01 · FY2022 · CA
TempO-Seq for Preserved Tissues in Toxicity Testing Phase II
$979,864Bruce E. Seligmann · Biospyder Technologies, Inc. · R44 · FY2017 · ES
PLCO EEMS and Extended Follow Up
$979,773Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2014 · CA
Molecular Epidemiology Studies of Occupational and Environmental Exposures
$979,771Nathaniel Rothman · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
Nuclear Factor-kappaB in Ovarian Cancer
$979,598Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Bifunctional T cell receptor based immunotherapeutics
$979,275Hing C. Wong · Altor Bioscience. Llc · R44 · FY2011 · CA
Optimizing Radiosynthetic Yield of [18F]FTT For Wide-Spread Distribution
$979,093Michel Mikhail · Trevarx Biomedical, Inc. · R42 · FY2024 · CA
Rare genitourinary tumors projects
$978,735Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Scaling Social Determinants of Health Screening, Social Support and Anti-Racism Training to Reduce Inequities in Minority Cancer Survivor Health and Wellbeing in Washington, DC
$978,463Hannah Arem · Medstar Health Research Institute · U01 · FY2021 · DP
Tumor stem cells and metastatic outcomes in mouse models of prostate cancer
$978,122Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
POPULATION BASED CASE CONTROLE STUDIES OF NOVEL BIOMARKERS FOR PROSTATE CANCER
$978,053The Johns Hopkins University · · FY2011 · Department of Defense
1/3 Florida-California Cancer Research, Education and Engagement (CaRE2) Health Equity Center
$977,974Romonia Renee Reams · Florida Agricultural And Mechanical Univ · U54 · FY2019 · CA
Increasing Physical Activity in Rural Pennsylvanians: The PA Moves Trial
$977,596Kathryn H. Schmitz · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
MOLECULAR CLASSIFICATION OF PROSTATE CANCER
$977,375Sloan-Kettering Institute For Cancer Res · U01 · FY2003 · CA
Redes En Accion::The National Hispanic/Latino Cancer Network Research Network
$977,248Amelie G Ramirez · University Of Texas Hlth Science Center · U54 · FY2014 · CA
GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER
$976,974Dana-Farber Cancer Institute · U01 · FY2002 · CA
PRECLINICAL EVALUATION OF ANTIGEN-SPECIFIC DNA VACCINES AS A TREATMENT FOR PROSTATE CANCER
$976,673University Of Wisconsin System · · FY2008 · Department of the Army
Inducing Proximity: An Emerging Paradigm for New Therapeutic Modalities
$976,573Craig M Crews · Yale University · R35 · FY2025 · CA
South Carolina Cancer Disparities Research Center (SC CADRE)
$976,404Marvella Elizabeth Ford · Medical University Of South Carolina · U54 · FY2019 · CA
Integrating targeted therapy and immunotherapy to break through cancer
$976,251Jean Zhao · Dana-Farber Cancer Inst · R35 · FY2024 · CA